Загрузка...
Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence
Seasonal influenza is a very common disease. Yearly vaccination of at-risk population groups is a well-recognized cost-effective/cost-saving preventive measure. It is, however, unclear which available alternative has the most favorable economic profile. Some available options are: trivalent (TIV) an...
Сохранить в:
| Опубликовано в: : | Hum Vaccin Immunother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6605847/ https://ncbi.nlm.nih.gov/pubmed/30735465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1578597 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|